11 – 20 of 304
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Use of flutemetamol F18-labeled positron emission tomography and other biomarkers to assess risk of clinical progression in patients with amnestic mild cognitive impairment
(
- Contribution to journal › Article
-
Mark
Economic Evaluation of Pharmacological Treatments in Dementia Disorders - A Systematic Literature Review
2018) In Working Papers(
- Working paper/Preprint › Working paper
-
Mark
Economic Evaluation of Management of Dementia Patients - A Systematic Literature Review
2018) In Working Papers, Lund University(
- Working paper/Preprint › Working paper
-
Mark
Economic Evaluation of Nonpharmacological Interventions for Dementia Patients and their Caregivers - A Systematic Literature Review
2018) In Working Papers(
- Working paper/Preprint › Working paper
-
Mark
Sex-specific genetic predictors of Alzheimer’s disease biomarkers
(
- Contribution to journal › Article
-
Mark
Short-term response to cholinesterase inhibitors in Alzheimer’s disease delays time to nursing home placement
(
- Contribution to journal › Article
-
Mark
Economic Evaluation of Interventions for Screening of Dementia
2018) In Working Papers(
- Working paper/Preprint › Working paper
-
Mark
Cerebrospinal fluid biomarker levels: Total tau and phosphorylated tau as markers for rate of progression in Alzheimer’s disease.
2018) Advances in Alzheimer’s and Parkinson’s Therapies (AAT-AD/PD) Focus Meeting 2018(
- Contribution to conference › Abstract
- 2017
-
Mark
Genome-wide, high-content siRNA screening identifies the Alzheimer’s genetic risk factor FERMT2 as a major modulator of APP metabolism
(
- Contribution to journal › Article
-
Mark
The effect of white matter hyperintensities on statistical analysis of diffusion tensor imaging in cognitively healthy elderly and prodromal Alzheimer’s disease
(
- Contribution to journal › Article